Global Ophthalmology Drugs Market to 2022 – Angiogenesis Modulators and Gene Therapies to Boost Overall … – Medgadget (blog)
|
Global Ophthalmology Drugs Market to 2022 – Angiogenesis Modulators and Gene Therapies to Boost Overall …
Medgadget (blog) ResearchMoz added Latest Research Report titled ” Global Ophthalmology Drugs Market to 2022-Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period ” to it’s Large Report database. Ophthalmology is a therapy … |
BioPharma-Reporter.com |
BioMarin building CA plant to support Factor VIII gene therapy candidate
BioPharma-Reporter.com “Our new gene therapy manufacturing facility is expected to be completed by mid-year, enabling us to move the BMN 270 program forward, without constraints on materials needed for the Phase 2b registration enabling study in the third quarter,” CEO … |
|
BioMarin building CA plant to support Factor VIII gene therapy candidate
BioPharma-Reporter.com “Our new gene therapy manufacturing facility is expected to be completed by mid-year, enabling us to move the BMN 270 program forward, without constraints on materials needed for the Phase 2b registration enabling study in the third quarter,” CEO … |
|
美 브로드연구소, ‘CRISPR–Cpf1‘ 유럽특허 확보
바이오스펙테이터 최근 유전자 가위 ‘CRISPR-Cas9′ 미국 특허 분쟁에 승리한 브로드 연구소(Broad Institute of MIT and Havard)가 차세대 유전자가위 ‘CRISPR–Cpf1‘의 유럽 특허를 확보했다. 브로드연구소는 27일(현지시간) “유럽특허청(EPO)이 2015년 6월 출원한 CRISPR–Cpf1의 … |
Genetic Literacy Project |
Muscle-wasting disease in dogs cured using gene therapy, offering hope to suffering boys
Genetic Literacy Project For decades, some unlucky dog lovers have [witnessed their puppies’] seemingly healthy muscles literally waste away…until they could no longer stand and breathe. [T]he genetic cause of this specific muscle-wasting disease…[is] a single mutation that … |
Synapse |
The CRISPR Quandary
Synapse With the advent of CRISPR technology, editing human genomes is no longer the stuff of science fiction. But Hank Greely, a Stanford law professor and bioethicist, isn’t too concerned: “I don’t think it’s very important, I don’t think it’s gonna happen … |
|
How immunotherapy can help treat solid tumors
Tribune-Review Greg Delgoffe, who researches cancer immunotherapy at the University of Pittsburgh, recently was awarded the Alliance for Cancer Gene Therapy’s young investor grant. Delgoffe is trying to make immunotherapy, which has been effective fighting cancers of … |